CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Other acquisition Director acquired 302 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 302 shares (code L)
- 4 Other acquisition Director acquired 2,027 shares (code L)
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Other acquisition Director acquired 138 shares (code L)
- 4 Other acquisition Director acquired 299 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 299 shares (code L)
- 4 Other acquisition Director acquired 1,564 shares (code L)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Other acquisition Director acquired 88 shares (code L)
- 4 Other acquisition Director acquired 254 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 254 shares (code L)
- 4 Other acquisition Director acquired 1,314 shares (code L)
- 4 Open-market buy Director bought 121 shares at an average $3.29 ($398)
- 4 Open-market buy Director bought 262 shares at an average $3.29 ($862)
- 4 Open-market buy Chairman and CEO bought 262 shares at an average $3.29 ($862)
- 4 Open-market buy Director bought 1,372 shares at an average $3.29 ($4,516)
Page 3 of 52 · 1,039 filings